Treatment of juvenile Graves' disease and its ophthalmic complication: the 'European way'KRASSAS, G. E.European journal of endocrinology. 2004, Vol 150, Num 4, pp 407-414, issn 0804-4643, 8 p.Article

Thyroid disease and male reproductive functionKRASSAS, G. E; PERROS, P.Journal of endocrinological investigation (Testo stampato). 2003, Vol 26, Num 4, pp 372-380, issn 0391-4097, 9 p.Article

Gonadal effect of radiation from ¹³¹I in male patients with thyroid carcinomaKRASSAS, G. E; PONTIKIDES, N.Archives of andrology. 2005, Vol 51, Num 3, pp 171-175, issn 0148-5016, 5 p.Article

The role of octreoscan in thyroid eye diseaseKRASSAS, G. E; KAHALY, G. J.European journal of endocrinology. 1999, Vol 140, Num 5, pp 373-375, issn 0804-4643Article

Immunosuppressive therapy in patients with thyroid eye disease : an overview of current conceptsKRASSAS, G. E; HEUFELDER, A. E.European journal of endocrinology. 2001, Vol 144, Num 4, pp 311-318, issn 0804-4643Article

Thyroid Function and Human Reproductive HealthKRASSAS, G. E; POPPE, K; GLINOER, D et al.Endocrine reviews. 2010, Vol 31, Num 5, pp 702-755, issn 0163-769X, 54 p.Article

Childhood Graves' ophthalmopathy : results of a European questionnaire studyKRASSAS, G. E; SEGNI, M; WIERSINGA, W. M et al.European journal of endocrinology. 2005, Vol 153, Num 4, pp 515-520, issn 0804-4643, 6 p.Article

Current concepts concerning orbital radiotherapy in patients with thyroid eye disease. Author's replyKRASSAS, G. E; PRUMMEL, M. F.European journal of nuclear medicine. 2001, Vol 28, Num 2, pp 254-257, issn 0340-6997Article

Psychological implications of Graves' orbitopathyCOULTER, I; FREWIN, S; KRASSAS, G. E et al.European journal of endocrinology. 2007, Vol 157, Num 2, pp 127-131, issn 0804-4643, 5 p.Article

Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye diseaseKRASSAS, G. E; DUMAS, A; PONTIKIDES, N et al.Clinical endocrinology (Oxford. Print). 1995, Vol 42, Num 6, pp 571-580, issn 0300-0664Article

A prospective controlled study of the impact of hyperthyroidism on reproductive function in malesKRASSAS, G. E; PONTIKIDES, N; DELIGIANNI, V et al.The Journal of clinical endocrinology and metabolism. 2002, Vol 87, Num 8, pp 3667-3671, issn 0021-972XArticle

A questionnaire survey on the management of Graves' orbitopathy in EuropePERROS, P; BALDESCHI, L; MARCOCCI, C et al.European journal of endocrinology. 2006, Vol 155, Num 2, pp 207-211, issn 0804-4643, 5 p.Article

Lanreotide in the treatment of patients with thyroid eye diseaseKRASSAS, G. E; KALTSAS, T; DUMAS, A et al.European journal of endocrinology. 1997, Vol 136, Num 4, pp 416-422, issn 0804-4643Article

Serum leptin values in relation to bone density and growth hormone-insulin like growth factors axis in healthy menPAPADOPOULOU, F; KRASSAS, G. E; KALOTHETOU, C et al.Archives of andrology. 2004, Vol 50, Num 2, pp 97-103, issn 0148-5016, 7 p.Article

Leptin concentrations during oral glucose tolerance test (OGTT) in obese and normal weight womenBOUGOULIA, M; TZOTZAS, T; EFTHYMIOU, H et al.International journal of obesity. 1999, Vol 23, Num 6, pp 625-628, issn 0307-0565Article

Disturbances of menstruation in hypothyroidismKRASSAS, G. E; PONTIKIDES, N; KALTSAS, T et al.Clinical endocrinology (Oxford. Print). 1999, Vol 50, Num 5, pp 655-659, issn 0300-0664Article

Leptin levels in women with polycystic ovary syndrome before and after treatment with diazoxideKRASSAS, G. E; KALTSAS, T. T; PONTIKIDES, N et al.European journal of endocrinology. 1998, Vol 139, Num 2, pp 184-189, issn 0804-4643Article

Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye diseaseKRASSAS, G. E; PONTIKIDES, N; KALTSAS, T et al.The Journal of clinical endocrinology and metabolism. 2003, Vol 88, Num 1, pp 132-135, issn 0021-972X, 4 p.Article

Growth hormone, insulin growth factor-1, and IGF binding protein-3 axis relationship with bone mineral density among healthy menKRASSAS, G. E; PAPADOPOULOU, Ph; KOLIAKOS, G et al.Archives of andrology. 2003, Vol 49, Num 3, pp 191-199, issn 0148-5016, 9 p.Article

Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndromeKALTSAS, T; PONTIKIDES, N; KRASSAS, G. E et al.Human reproduction (Oxford. Print). 1998, Vol 13, Num 1, pp 22-26, issn 0268-1161Article

Age-related changes in bone density among healthy Greek malesKRASSAS, G. E; PAPADOPOULOU, F. G; DOUKIDIS, D et al.Journal of endocrinological investigation (Testo stampato). 2001, Vol 24, Num 5, pp 326-333, issn 0391-4097Article

Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndromeKALTSAS, T; PONTIKIDES, N; KRASSAS, G. E et al.Human reproduction (Oxford. Print). 1999, Vol 14, Num 11, pp 2704-2708, issn 0268-1161Article

Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' OrbitopathyBARTALENA, L; KRASSAS, G. E; AZZOLINI, C et al.The Journal of clinical endocrinology and metabolism. 2012, Vol 97, Num 12, pp 4454-4463, issn 0021-972X, 10 p.Article

Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical proceduresMOURITS, M. P; BIJL, H; KAHALY, G. J et al.British journal of ophthalmology. 2009, Vol 93, Num 11, pp 1518-1523, issn 0007-1161, 6 p.Article

Clinical assessment of patients with Graves' orbitopathy : the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchersWIERSINGA, W. M; PERROS, P; LANE, C. M et al.European journal of endocrinology. 2006, Vol 155, Num 3, pp 387-389, issn 0804-4643, 3 p.Article